Leading COVID-19 vaccine candidate Moderna confirmed that its drug will not be ready for emergency approval until late November, and won't be available for widespread public distribution until spring 2021. Health experts have supported this timeline, contradicting President Trump. Amid the race for a coronavirus vaccine, the chief executive of one of the leading vaccine contenders said that the company's drug most ...